Lymphocyte activation gene-3 as a candidate target for combo anti-programmed death-(ligand) 1 therapy of cancer
| Autor: | Mortezaee, Keywan |
|---|---|
| Zdroj: | In Process Biochemistry February 2024 137:143-152 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
| Autor: | Mortezaee, Keywan |
|---|---|
| Zdroj: | In Process Biochemistry February 2024 137:143-152 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect